New insights into KATP channel gene mutations and neonatal diabetes mellitus
- 6 May 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Endocrinology
- Vol. 16 (7), 378-393
- https://doi.org/10.1038/s41574-020-0351-y
Abstract
The ATP-sensitive potassium channel (KATP channel) couples blood levels of glucose to insulin secretion from pancreatic β-cells. KATP channel closure triggers a cascade of events that results in insulin release. Metabolically generated changes in the intracellular concentrations of adenosine nucleotides are integral to this regulation, with ATP and ADP closing the channel and MgATP and MgADP increasing channel activity. Activating mutations in the genes encoding either of the two types of KATP channel subunit (Kir6.2 and SUR1) result in neonatal diabetes mellitus, whereas loss-of-function mutations cause hyperinsulinaemic hypoglycaemia of infancy. Sulfonylurea and glinide drugs, which bind to SUR1, close the channel through a pathway independent of ATP and are now the primary therapy for neonatal diabetes mellitus caused by mutations in the genes encoding KATP channel subunits. Insight into the molecular details of drug and nucleotide regulation of channel activity has been illuminated by cryo-electron microscopy structures that reveal the atomic-level organization of the KATP channel complex. Here we review how these structures aid our understanding of how the various mutations in the genes encoding Kir6.2 (KCNJ11) and SUR1 (ABCC8) lead to a reduction in ATP inhibition and thereby neonatal diabetes mellitus. We also provide an update on known mutations and sulfonylurea therapy in neonatal diabetes mellitus.Keywords
This publication has 159 references indexed in Scilit:
- Functional Characterization of a Novel KCNJ11 in Frame Mutation-Deletion Associated with Infancy-Onset Diabetes and a Mild Form of Intermediate DEND: A Battle between KATP Gain of Channel Activity and Loss of Channel ExpressionPLOS ONE, 2013
- Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8)FEBS Letters, 2011
- Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live birthsActa Diabetologica, 2011
- Permanent diabetes during the first year of life: multiple gene screening in 54 patientsDiabetologia, 2011
- Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutationDiabetologia, 2010
- PIP2-Binding Site in Kir Channels: Definition by Multiscale Biomolecular SimulationsBiochemistry, 2009
- Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinismEMBO Molecular Medicine, 2009
- A mutation (R826W) in nucleotide‐binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetesEMBO Reports, 2008
- A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complicationsDiabetologia, 2008
- Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysisThe EMBO Journal, 2007